Drug information provided by: Merative, Micromedex®
Respiratory syncytial virus vaccine is an active immunizing agent used to prevent lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in patients 60 years of age and older and in patients 50 to 59 years of age who are at increased risk for LRTD. It works by causing your body to produce its own protection (antibodies) against the disease.
Respiratory syncytial virus can cause serious breathing problems that may require hospitalization.
This vaccine is to be given only by or under the supervision of your doctor.
This product is available in the following dosage forms:
Portions of this document last updated: Aug. 01, 2024
Copyright: © Merative US L.P. 1973, 2024. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Thanks to generous benefactors, your gift today can have 5X the impact to advance AI innovation at Mayo Clinic.